Literature DB >> 32727328

SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan.

Priya Mishra1, Amit Kumar Mittal2, Harikesh Kalonia3, Swati Madan3, Shampa Ghosh4, Jitendra Kumar Sinha1, Satyendra Kumar Rajput2.   

Abstract

Neurodegeneration is a complex neurological phenomenon characterized by disturbed coherence in neuronal efflux. Progressive neuronal loss and brain damage due to various age-related pathological hallmarks perturb the behavioral balance and quality of life. Sirtuins have been widely investigated for their neuroprotective role, with SIRT1 being the most contemplated member of the family. SIRT1 exhibits significant capabilities to enhance neurogenesis and cellular lifespan by regulating various pathways, which makes it an exciting therapeutic target to inhibit neurodegenerative disease progression. SIRT1 mediated neuronal fortification involves modulation of molecular co-factors and biochemical pathways responsible for the induction and sustenance of pro-inflammatory and pro-oxidative environment in the cellular milieu. In this review, we present the major role played by SIRT1 in maintaining cellular strength through the regulation of genomic stability, neuronal growth, energy metabolism, oxidative stress, inhibiting mechanisms and anti-inflammatory responses. The therapeutic significance of SIRT1 has been put into perspective through a comprehensive discussion about its ameliorating potential against neurodegenerative stimuli in a variety of diseases that characteristically impair cognition, memory and motor coordination. This review enhances the acquaintance concerned with the neuroprotective potential of SIRT1 and thus promotes the development of novel SIRT1 regulating therapeutic agents and strategies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  SIRT1; genomic stability; neuoroprotection; neurodegenerative disease.; neurogenesis; oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 32727328      PMCID: PMC8686317          DOI: 10.2174/1570159X18666200729111744

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  169 in total

Review 1.  Immunotherapeutic approaches to Alzheimer's disease.

Authors:  Alon Monsonego; Howard L Weiner
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

Review 2.  Sirtuins in neurodegenerative diseases: a biological-chemical perspective.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

Review 3.  Mitochondrial DNA nucleoid structure.

Authors:  Daniel F Bogenhagen
Journal:  Biochim Biophys Acta       Date:  2011-11-27

Review 4.  SIRT1 and neuronal diseases.

Authors:  Bor Luen Tang; Christelle En Lin Chua
Journal:  Mol Aspects Med       Date:  2007-02-16

5.  Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1alpha expression in experimental stroke.

Authors:  Hai-rong Zhu; Zhong-yuan Wang; Xiao-lei Zhu; Xiao-xin Wu; Er-guang Li; Yun Xu
Journal:  Neuropharmacology       Date:  2010-04-08       Impact factor: 5.250

6.  SIRT1 protects against α-synuclein aggregation by activating molecular chaperones.

Authors:  Gizem Donmez; Anirudh Arun; Chee-Yeun Chung; Pamela J McLean; Susan Lindquist; Leonard Guarente
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

Review 7.  Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning.

Authors:  Kahlilia C Morris; Hung Wen Lin; John W Thompson; Miguel A Perez-Pinzon
Journal:  J Cereb Blood Flow Metab       Date:  2011-01-12       Impact factor: 6.200

8.  Poly(ADP-ribose) polymerase 1-sirtuin 1 functional interplay regulates LPS-mediated high mobility group box 1 secretion.

Authors:  Thomas D Walko; Valentina Di Caro; Jon Piganelli; Timothy R Billiar; Robert S B Clark; Rajesh K Aneja
Journal:  Mol Med       Date:  2015-03-12       Impact factor: 6.354

Review 9.  Sirt1 and the Mitochondria.

Authors:  Bor Luen Tang
Journal:  Mol Cells       Date:  2016-02-02       Impact factor: 5.034

10.  Recent Advances in Epilepsy.

Authors:  Yang Jin; Xiaoxiao Yao; Lihua Sun; Wei Yang; Ranji Cui; Bingjin Li
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

View more
  4 in total

1.  Time-course miRNA alterations and SIRT1 inhibition triggered by adolescent lead exposure in mice.

Authors:  Rundong Liu; Yawei Wang; Lin Bai; Ruike Wang; Yingying Wu; Mengchen Liu; Qiong Li; Yue Ba; Huizhen Zhang; Guoyu Zhou; Xuemin Cheng; Hui Huang
Journal:  Toxicol Res (Camb)       Date:  2021-06-07       Impact factor: 2.680

Review 2.  Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1.

Authors:  Ruike Wang; Yingying Wu; Rundong Liu; Mengchen Liu; Qiong Li; Yue Ba; Hui Huang
Journal:  J Mol Med (Berl)       Date:  2022-03-11       Impact factor: 4.599

3.  MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression.

Authors:  Danielle Yaron-Saminsky; Karthik Nagaraj; Rive Sarfstein; Zvi Laron; Metsada Pasmanik-Chor; Haim Werner
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

4.  Alzheimer's Amyloid-β Accelerates Cell Senescence and Suppresses the SIRT1/NRF2 Pathway in Human Microglial Cells.

Authors:  Yuqian An; Yi Li; Yujun Hou; Shichao Huang; Gang Pei
Journal:  Oxid Med Cell Longev       Date:  2022-08-17       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.